Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04810624 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Relapse Prevention and Changing Habits in Anorexia Nervosa

Study acronym: REACH+
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Suspended to Recruiting
    • Study completion moved earlier from Jun 1, 2028 to Jun 1, 2027
    • Site details revised
    v14
  2. Study completion pushed from Jun 30, 2027 to Jun 1, 2028
    • Primary completion date: Jun 30, 2027 to Jun 1, 2027
    v13
  3. Primary and study completion dates: Jan 30, 2026 to Jun 30, 2027v12
  4. Primary and study completion dates: Jan 30, 2025 to Jan 30, 2026v11
  5. Re-verified, no change to tracked fieldsv10
Show 8 earlier versionsHide 8 earlier versions
  1. Trial status: Recruiting to Suspended Sponsor's reason: U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects…
    • Site details revised
    v9
  2. Collaborators: 2 to 3v8
  3. Re-verified, no change to tracked fieldsv7
  4. Start date: Jul 1, 2021 to Jun 21, 2021v6
  5. Enrollment target: 15 to 60v5 Show 6 more changesShow less
    • Primary endpoints: 3 to 1
    • Interventions: Relapse Prevention and Changing Habits + (Behavioral) to Relapse Prevention and Changing Habits (REACH+) (Behavioral)
    • Eligibility criteria expanded, about 33 words
    • Secondary endpoints: 1 to 5
    • Study description expanded, about 39 words
    • Study arms: 1 to 26
  6. Primary and study completion dates: Jan 30, 2023 to Jan 30, 2025v4
  7. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  8. Start date: Apr 1, 2021 to Jul 1, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package. In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.
Trial Details
NCT Number NCT04810624
Lead Sponsor New York State Psychiatric Institute
Collaborators: Columbia University, Brown University, National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 Anorexia Nervosa
Related terms Anorexia Nervosa
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov